Article
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation
24 Feb 2014
Abstract excerpt
The use of pegylated interferon-α (pegIFN-α) has replaced unmodified recombinant IFN-α for the treatment of chronic viral hepatitis. While the superior antiviral efficacy of pegIFN-α is generally attributed to improved pharmacokinetic properties, the pharmacodynamic effects of pegIFN-α in the liver have not been studied. Here, we analyzed pegIFN-α-induced signaling and gene regulation in paired liver biopsies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
